Gastrointestinal (GI) cancer is a term for the group of cancers that affect the digestive system. This includes cancers of the esophagus, gallbladder & biliary tract, liver, pancreas, stomach, small intestine, bowel (large intestine or colon and rectum), and anus.
Jump to Studies
Gastric, Esophageal and GEJ | Colorectal | Pancreatic | Liver
We have several clinical trials that are currently recruiting to evaluate experimental medications for gastrointestinal (GI) cancer. See if there are clinical trials that might be right for you.
Thank you for Considering a Clinical Trial
Below you will find clinical trials that are either currently recruiting patients (noted as Recruiting) or starting to recruit patients soon (noted as Not Yet Recruiting).
Here are some options for you to find more information:
An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors
View Trial DetailsAn Investigational Immuno-therapy Study of Nivolumab or Placebo in Patients With Resected Esophageal or Gastroesophageal Junction Cancer
View Trial DetailsEfficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer
View Trial DetailsA Study to Test Combination Treatments in Patients With Advanced Gastric Cancer
View Trial DetailsA Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin
View Trial DetailsAn Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread
View Trial DetailsAn Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers
View Trial DetailsA Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
View Trial DetailsAn Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Patients With Previously Treated Cancer of the Colon or Rectum That Has Spread
View Trial DetailsAn Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has Spread
View Trial DetailsA Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)
View Trial DetailsA Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
View Trial DetailsA Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer
View Trial DetailsA Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)
A Study of Nivolumab in Patients With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
View Trial DetailsA Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)
View Trial DetailsGet updates on clinical trials
Let us help you find a trial you might qualify for
Share your experience and learn from others.
Join the Conversation
Hear what past clinical trial patients have to say about their experience
"I noticed a red spot on my shoulder and didn't think too much about it, but after a few more days it didn't change. Nancy recommended that I probably ought to get it checked"
"I noticed a red spot on my shoulder and didn't think too much about it, but after a few more days it didn't change. Nancy recommended that I probably ought to get it checked"
View Story
"They want you to be as safe as possible. So as soon as they notice something is off, they will tell you. And you have the option of saying, 'OK, I'm out.'"
"They want you to be as safe as possible. So as soon as they notice something is off, they will tell you. And you have the option of saying, 'OK, I'm out.'"
View Story
"The medical oncologist did lay out exactly what was going to happen if I did go through this clinical trial, so there weren't any surprises"
"The medical oncologist did lay out exactly what was going to happen if I did go through this clinical trial, so there weren't any surprises"
View StoryThe signs & symptoms of gastric cancer can vary depending on the stage of the cancer. In general, symptoms may also be associated with other conditions. Talk to your doctor if you have any of these symptoms.
Learn More
Bristol-Myers Squibb is not affiliated with nor endorses any of the listed organizations. The information/links provided by Bristol-Myers Squibb are meant for informational purposes only and are not meant to replace a physician's medical advice or imply endorsement.
